ArticleThe Biochemical journal2026
Nuclear translocation of mitochondrial ferredoxin reductase is regulated by AKT-mediated phosphorylation.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ferredoxin reductase (FDXR) is the sole ferredoxin reductase in humans and plays an essential role for steroidogenesis and biosynthesis of heme and iron-sulfur cluster (ISC) by transferring electrons from NADPH to ISC-containing ferredoxin 1 (FDX1) and FDX2. In this study, we found that while FDXR is classified as a mitochondria-localized flavoprotein, it can be translocated into the nucleus, especially in response to various stress signals. Next, we identified a bipartite nuclear localization signal within amino acids 271-299 of FDXR, the disruption of which impairs its nuclear translocation. Further, we found that AKT can phosphorylate threonine 277 adjacent to the NLS in FDXR and subsequently enhances its nuclear translocation. Consistent with this, mutant FDXR(T277A), in which threonine 277 was substituted with alanine, impaired FDXR nuclear translocation. Together, our data provide evidence that the mitochondrial FDXR can be translocated to the nucleus, which is regulated by AKT-mediated phosphorylation, especially in response to cellular stress. Our data suggest that FDXR plays a role in the mitochondria-nucleus communication and stress responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.